Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
종목 코드 NAGE
회사 이름Niagen Bioscience Inc
상장일Jun 25, 2007
CEOFried (Robert N)
직원 수104
유형Ordinary Share
회계 연도 종료Jun 25
주소10900 Wilshire Blvd Suite 600
도시LOS ANGELES
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호90024
전화13103886706
웹사이트https://www.niagenbioscience.com/
종목 코드 NAGE
상장일Jun 25, 2007
CEOFried (Robert N)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음